We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more
WESTLAKE VILLAGE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first...
– Continued active enrollment of Olvi-Vec in our pivotal Phase 3 OnPrime/GOG-3076 trial in platinum resistant/refractory ovarian cancer with topline results anticipated in 2H 2025 – – Initiation...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.03 | 0.757575757576 | 3.96 | 4 | 3.34 | 105378 | 3.64790673 | CS |
| 4 | 0.12 | 3.1007751938 | 3.87 | 4.22 | 3.06 | 125506 | 3.56066713 | CS |
| 12 | -2.89 | -42.0058139535 | 6.88 | 8.668 | 3.06 | 124777 | 5.02027914 | CS |
| 26 | -9.06 | -69.4252873563 | 13.05 | 16.6 | 3.06 | 127580 | 8.30978894 | CS |
| 52 | -21.7 | -84.4686648501 | 25.69 | 40.98 | 3.06 | 135861 | 16.3238002 | CS |
| 156 | -2.01 | -33.5 | 6 | 40.98 | 3.06 | 129695 | 17.03838328 | CS |
| 260 | -2.01 | -33.5 | 6 | 40.98 | 3.06 | 129695 | 17.03838328 | CS |
Monksdream
1 month ago
Monksdream
1 month ago
MiamiGent
6 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
